MedTrace Logo

Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1

NCT00000309 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2015-07-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Risperidone

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • VA Boston Healthcare System

    collaborator FED

  • Butler Hospital

    lead OTHER

Principal Investigators

  • Lawrence Price, M.D. · Brown University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-08-31
Primary Completion
2000-01-31
Completion
2000-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000309 on ClinicalTrials.gov